Yifei Li Selected Research

Glioma (Gliomas)

1/2021	Canstatin represses glioma growth by inhibiting formation of VM-like structures.
2/2016	Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo.
10/2015	Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yifei Li Research Topics

Disease

19	Neoplasms (Cancer) 04/2022 - 09/2008
7	Heart Failure 01/2022 - 04/2015
7	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 02/2021 - 01/2019
6	Infections 02/2022 - 01/2009
5	Cardiac Arrhythmias (Arrythmia) 11/2021 - 04/2018
4	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 01/2012
4	Cardiomyopathies (Cardiomyopathy) 11/2021 - 01/2018
4	Neoplasm Metastasis (Metastasis) 09/2021 - 11/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2017
4	Inflammation (Inflammations) 01/2021 - 01/2016
3	Sepsis (Septicemia) 11/2022 - 01/2021
3	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 09/2008
3	Hypoxia (Hypoxemia) 01/2022 - 12/2018
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2021 - 01/2018
3	Cardiomegaly (Heart Hypertrophy) 03/2021 - 01/2017
3	Glioma (Gliomas) 01/2021 - 10/2015
3	Fibrosis (Cirrhosis) 01/2021 - 01/2016
3	Ventricular Heart Septal Defects (Ventricular Septal Defect) 11/2020 - 06/2015
3	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2014
2	Osteoarthritis 01/2022 - 04/2020
2	Edema (Dropsy) 01/2022 - 06/2014
2	Diarrhea 01/2022 - 01/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2018
2	Hemoptysis 01/2022 - 02/2019
2	Tachycardia (Tachyarrhythmias) 01/2022 - 11/2013
2	Mycoses (Diseases, Fungus) 11/2021 - 01/2019
2	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 01/2020
2	Carcinogenesis 10/2021 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2018
2	COVID-19 01/2021 - 01/2021
2	Fever (Fevers) 10/2020 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 10/2020 - 05/2014
2	Patent Ductus Arteriosus 02/2020 - 06/2015
2	Maternal Obesity 01/2020 - 10/2015
2	Congenital Abnormalities (Deformity) 11/2019 - 01/2019
2	Congenital Heart Defects (Congenital Heart Defect) 01/2019 - 06/2015
2	Polymorphic catecholergic ventricular tachycardia 01/2019 - 04/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2016
2	Endometrial Neoplasms (Endometrial Cancer) 04/2016 - 08/2014
2	Obesity 01/2016 - 10/2015
2	Atrial Heart Septal Defects (Atrial Septal Defect) 06/2015 - 08/2013
2	Carcinoma (Carcinomatosis) 10/2014 - 05/2014
1	Hepatitis C 04/2022
1	Residual Neoplasm 04/2022
1	Rectal Neoplasms (Rectal Cancer) 04/2022
1	Infertility (Sterility) 03/2022
1	Reperfusion Injury 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Atrial Flutter (Flutter, Atrial) 01/2022
1	Robinow Syndrome 01/2022
1	Supraventricular Tachycardia 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Disease Progression 01/2022
1	Myocardial Infarction 01/2022
1	Wounds and Injuries (Trauma) 01/2022

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2009
9	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
8	Biomarkers (Surrogate Marker)IBA 04/2022 - 08/2014
7	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2019
7	Digoxin (Digitek)FDA LinkGeneric 01/2022 - 11/2013
5	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 01/2022 - 09/2008
4	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2018
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 10/2015
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2018
3	CytokinesIBA 11/2020 - 11/2013
2	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2021
2	Biological ProductsIBA 04/2022 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2021
2	CalciumIBA 01/2022 - 11/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 01/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 10/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2010
2	OligonucleotidesIBA 10/2020 - 01/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 04/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2016
1	Troponin IIBA 11/2022
1	Natriuretic PeptidesIBA 11/2022
1	Cell-Free Nucleic AcidsIBA 04/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2022
1	Contraceptive Agents (Contraceptives)IBA 03/2022
1	Antisense OligonucleotidesIBA 01/2022
1	AntigensIBA 01/2022
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2022
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2022
1	Flecainide (Tambocor)FDA LinkGeneric 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	NucleotidesIBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 01/2022

Therapy/Procedure

15	Therapeutics 01/2022 - 09/2008
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2011
3	Mechanical Ventilators (Ventilator) 01/2022 - 11/2020
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2015
2	Radiotherapy 10/2021 - 01/2020
2	Transplantation 11/2020 - 01/2018
2	Septal Occluder Device 08/2020 - 08/2013
1	Neoadjuvant Therapy 04/2022